Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Megalestari Epack Sentosaraya Tbk. (EPAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Megalestari Epack Sentosaraya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Megalestari Epack Sentosaraya Tbk. trades at Rp61 (market cap 198.2B, 480.08M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Megalestari Epack Sentosaraya Tbk. is more actively traded (480.08M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | EPAC | |
|---|---|---|
Market Cap | 316.25B | 198.2B |
Volume | 41.7K | 480.08M |
Lot | 417 | 4.8M |
Turnover | 9.66M | 29.89B |
Average Price | 231.65 | 62.25 |
Value | 9.66M | 29.89B |
Indicative Equilibrium Price | 230 | 61 |
Indicative Equilibrium Volume | 2.4K | 51.75K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Megalestari Epack Sentosaraya Tbk.
PT Megalestari Epack Sentosaraya Tbk ("Company") formerly PT Era Prima Adi Cipta Kreasindo and its subsidiaries (together the "Group") was established based on the Deed No.55, dated June 18, 2013 of Poppie Savitri Martosuhardjo Pharmanto, S.H., notary in Jakarta.
Read more on EPAC →
